Pds biotech to participate in the h.c. wainwright 27th annual global investment conference

Princeton, n.j., sept. 02, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the company will participate in the 27th annual h.c.
PDSB Ratings Summary
PDSB Quant Ranking